Computational Health Center

Researchers at Helmholtz Munich and the Technical University of Munich have made significant progress in advancing high-resolution optoacoustic imaging for clinical use. Their innovative deep-learning framework, known as DeepMB, holds great promise…

A collaborative endeavor between computer scientists and diabetes researchers at Helmholtz Munich has yielded novel insights into the mechanisms underlying type 1 and type 2 diabetes. This collaboration has resulted in the creation of the first mouse…

Helmholtz Munich and the Eric and Wendy Schmidt Center at the Broad Institute launch Collaborative Research Initiative

Helmholtz Munich and the Eric and Wendy Schmidt Center at the Broad Institute of MIT and Harvard announced the launch of a…

Dr. Michael Zech received the David Marsden Award 2023 from Dystonia Europe at the 9th EAN Congress in Budapest, Hungary. The award recognizes his groundbreaking research on the genetics of movement disorders, particularly dystonia.

Prof. Fabian Theis, the AI expert, Director of the Computational Health Center at Helmholtz Munich, and Coordinator of Helmholtz AI takes on another important role for AI-based medical research: As Director for Biomedical AI, he complements the…

The International Society for Computational Biology (ISCB) annually recognizes exceptional individuals in the fields of computational biology and bioinformatics through its prestigious Fellows program. This year, Prof. Fabian Theis, Head of the…

Can a human organ be mapped on a single-cell level to learn about the functionality of each individual cell? And can we learn how different these cells are from person to person? Helmholtz Munich researchers and their collaborators have taken up this…

A new ad hoc working group with the topic of “artificial intelligence in medicine” started at the Bavarian Academy of Sciences and Humanities (BAdW). The project is planned for three years and will be executed by the Bavarian Academy of Sciences and…

Analysis of genes can help in detecting diseases at an early stage as well as in determining new drug targets for therapy. Thanks to extremely powerful data processing, the field holds great promise for advancement. Helmholtz Munich is particularly…

The German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) awarded Fabian Theis the Gottfried Wilhelm Leibniz Prize – the most prestigious research award in Germany. Fabian Theis is Head of the Computational Health Center at Helmholtz…

In the future, blood samples from patients can be evaluated not only by specialists, but also by artificial intelligence. A team from Helmholtz Munich is laying the foundations for this.

Mohammad Lotfollahi wins the prestigious Bayer Foundation "Early Excellence in Science Award" in the category "Data Sciences" in Life Sciences for his pioneering machine learning algorithms.

Blood Bots

By leveraging the power of AI, computers can detect leukemia in blood samples – with accuracy to match their human counterparts

How do single cells communicate in a tissue? How can these interactions be modeled, while retaining information of spatial context? Researchers around Fabian Theis from Helmholtz Munich Computational Health Center and Technical University of Munich…

Fabian Theis and Ele Zeggini's interview

Over the next five years, the interdisciplinary NEUROCOV consortium will investigate the role of the host-virus interplay in the occurrence of neurological and psychiatric symptoms resulting from COVID-19 as a foundation for new treatment options.

The MDSI congratulates the awardees of the MDSI Best Paper of the Year Award 2021. Runner-up goes to first author Mohammad Lotfollahi from ICB!

In October, we kicked off our new project HOPARL at Helmholtz Munich, together with experts and scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI), the Technical University of Munich (TUM), and the University of Würzburg.

Dr. Sarah Kim-Hellmuth, Research Group Leader at the Helmholtz Munich Institute of Translational Genomics will be awarded the Friedmund Neumann Prize 2022 for her groundbreaking work in studying the genetic influence on human gene activity.

Cardiomyopathy is not a uniform disease. Rather, individual genetic defects lead to heart failure in different ways, an international consortium with participation of Dr. Matthias Heinig, researcher at Helmholtz Munich, reports in Science.